Asterand plc has launched GLP-compliant molecular pathology services supporting preclinical safety studies. The company’s first new service offering will be tissue cross reactivity testing for therapeutic antibodies in order to supply clients with critical data required by regulatory authorities for IND submissions. Acceptance as a member of the UK GLP Compliance Monitoring Programme will also allow Asterand to expand its offering of GLP-compliant preclinical services to its pharmaceutical a...